Using genetic and epigenetic alterations found in early stage cancers we develop novel assays to help detect aggressive cancers at an early and treatable stage
📢 We're recruiting a Medical Imaging AI researcher!
Exciting project @CRUKCamBCVI (jointly shared with Mair and Price labs), integrating novel imaging datasets (DMI/MRI/PET) with whole genome & transcriptome data for real time clinical decision making.
https://t.co/QdY5RZSZbX
🧵 UM researchers have used #AI to distinguish between four #RenalCancer subtypes. This tech has the potential to improve pre-surgical diagnosis and avoid unnecessary surgery.
This excellent thread by @IzzyNewsham explains all 👇
I am extremely enthusiastic to share our work published today in @NatureGenet. We establish a targeted @nanopore sequencing approach for ultralong-read epigenomic profiling and discover a novel, primate-specific enhancer driving bi-allelic IGF2 expression. https://t.co/5bBpA8w89t
📢Congratulations @srossi725, PhD student in @Massie_Lab, whose paper on improving diagnostic accuracy of renal masses using a bespoke machine-learning model was published in @ScienceMagazine yesterday.
https://t.co/Ydt934eeRu
This is another paper from the CRUK-ICGC Prostate group that have been workling together for over 10 years and driven by Claudia Buhigas' PhD work. @davidcwedge @dralynch@Massie_Lab@EelesRos@VincentGnanapr3 etc.
On the day of our official launch, Institute Director Rebecca Fitzgerald @RFitzgerald_lab is interviewed on @BBCr4today.
Listen to the interview at 1:21:48.
#EarlyCancerCamLaunch
https://t.co/137iU1dz41
"We want to focus on some of the hardest cancers to treat where early detection could really make a difference."
Prof Rebecca Fitzgerald on @BBCr4today about the launch of the UK's first Early Cancer Institute
@Cambridge_Uni@EarlyCancerCam@CRUKresearch
https://t.co/liXhZnOe6f
An exciting opportunity to join our dynamic teams as part of an international collaboration on leading-edge methods for cell-free DNA methylation assays to facilitate effective cancer early detection: https://t.co/Pmlx8gOFLt
We are looking for highly motivated Research Associates to join an exciting collaborative project (UCL, Stanford, Cambridge) exploring the use of novel epigenomic methods for cancer early detection:
https://t.co/C301Mm7xU2
@AndyFeber and Richard Mair https://t.co/Z435Szou29
We're looking for a new Research Nurse to join the UM team. Know a registered nurse with oncology or clinical trials experience, who can work in a self-directed, independent and flexible manner? Send them our way 👉https://t.co/P8sq76gcmG
Cervical cancer rates reduced by 87% HPV vaccination!
To celebrate the results of our paper on HPV vaccination we spoke to Emeritus Professor of Epithelial Biology @Cambridge_Uni, Margaret Stanley about her lifetime in HPV research. https://t.co/UyXt4YL7yw
We know there's positive selection for mutations in cancer-associated genes in healthy tissues. But how much positive selection is there elsewhere in the genome? @gladyspoon investigated in our paper just out in @NatureGenet https://t.co/GOW4S0yyza
👏🎉Huge congratulations to @SerenaNikZainal awarded the 2021 @acmedsci Foulkes Foundation Medal for personalising treatments for cancer patients by identifying specific patterns of mutations in tumours
@CRUKresearch@CUH_NHS@Cambridge_Uni
➡️ https://t.co/vRTOEftHqU